2024년에 27억 달러로 추정되는 세계의 경피독성 시험 시장은 2024-2030년에 CAGR 7.5%로 성장하며, 2030년에는 41억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 경피독성 시험 서비스는 CAGR 8.9%를 기록하며, 분석 기간 종료시에는 24억 달러에 달할 것으로 예측됩니다. 경피독성 시험 제품 부문의 성장률은 분석 기간 중 CAGR 5.6%로 추정됩니다.
미국 시장은 6억 9,910만 달러, 중국은 CAGR 7.2%로 성장할 것으로 예측
미국의 경피독성 시험 시장은 2024년에 6억 9,910만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 6억 5,460만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 7.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 7.1%와 6.2%로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 것으로 예측됩니다.
세계의 경피독성 시험 시장 - 주요 동향과 촉진요인 정리
경피독성시험에 대한 수요가 급증하는 이유는?
안전하고 효과적인 스킨케어, 의약품, 화학제품에 대한 수요가 증가함에 따라 전 세계 경피독성시험 시장은 빠르게 성장하고 있습니다. 미국 식품의약국(FDA), 유럽화학물질청(ECHA) 등 규제기관이 엄격한 안전기준을 적용하고 있는 가운데, 기업은 자사 제품이 피부 자극이나 민감성, 장기적인 피부 손상을 유발하지 않도록 보장해야 합니다. 특히 화장품 및 퍼스널케어 업계에서는 크루얼티 프리 및 비동물실험 제품에 대한 수요가 급증하고 있으며, 대안적 방법의 채택이 더욱 가속화되고 있습니다. 또한 합성화학물질의 잠재적 부작용에 대한 소비자의 인식이 높아지면서 제조업체는 엄격한 안전성 평가를 우선시하고 있습니다. 피부과학 연구의 확대와 피부 관련 질환 증가로 인해 종합적인 경피독성시험에 대한 수요는 지속적으로 증가하고 있습니다.
기술 혁신은 경피독성 시험 시장을 어떻게 변화시키고 있는가?
기술의 발전은 경피 독성 시험의 상황을 크게 변화시켜 보다 신뢰할 수 있고, 윤리적이고, 비용 효율적인 솔루션을 도입하고 있습니다. 3D 인체 피부 모델과 같은 in vitro 시험법의 채택은 기존의 동물실험을 대체할 수 있는 우수한 대안을 제공하며, 인간의 피부 반응을 보다 정확하게 예측할 수 있게 되었습니다. 또한 하이스루풋 스크리닝(HTS) 기술과 첨단 생물정보학 툴을 통해 독성 분석이 가속화되어 연구자들은 여러 화합물을 동시에 평가할 수 있게 되었습니다. 독성 예측에 인공지능(AI)과 머신러닝의 통합은 데이터 분석을 더욱 강화하여 독성 평가의 효율성과 정확성을 향상시키고 있습니다. 또한 규제기관은 화학물질과 피부의 상호작용을 가상으로 시뮬레이션할 수 있는 인실리코(컴퓨터 기반) 모델링 기술을 옹호하고 있습니다. 이러한 기술적 진보는 경피독성시험의 미래를 형성하고 있으며, 보다 안전하고 윤리적인 제품 개발을 가능하게 하고 있습니다.
경피독성시험 시장에 영향을 미치는 주요 이슈는?
경피독성시험 분야의 발전에도 불구하고 몇 가지 과제는 경피독성시험의 성장과 표준화에 계속 영향을 미치고 있습니다. 주요 장애물 중 하나는 인간 피부 생리학의 복잡성으로 인해 보편적으로 적용 가능한 in vitro 모델을 만드는 것이 어렵습니다. 동물실험을 대체할 수 있는 방법은 발전하고 있지만, 규제 당국의 검증과 전 세계 보급에 시간이 걸리면서 이러한 모델의 보급이 늦어지고 있습니다. 또한 첨단 시험 기술과 관련된 높은 비용과 숙련된 전문가의 필요성은 중소기업의 재정적, 경영적 장벽으로 작용하고 있습니다. 또한 국가마다 안전 규정이 다르기 때문에 다국적 기업에게 컴플라이언스 문제가 발생하며, 지역별로 다른 테스트 요건을 지속적으로 준수해야 하는 어려움이 있습니다. 경피독성 시험 시장의 지속적인 성장을 위해서는 규제 조화, 연구에 대한 투자, 비용 효율적인 기술 혁신 증가를 통해 이러한 문제를 해결하는 것이 필수적입니다.
경피독성 시험 시장의 성장을 가속하는 요인은 무엇인가?
경피독성 테스트 시장의 성장은 규제 당국의 감시 강화, 안전하고 윤리적인 제품에 대한 소비자 수요 증가, 대체 테스트 방법의 발전 등 여러 요인에 의해 주도되고 있습니다. in vitro 및 in silico 시험법의 채택이 확대되고 있으며, AI를 활용한 예측 모델링을 통해 독성 평가의 신뢰성과 효율성이 향상되고 있습니다. 또한 제약, 화장품, 화학 산업의 확대로 엄격한 안전성 평가의 필요성이 높아지면서 시장 성장을 촉진하고 있습니다. 정부의 규제와 옹호 단체의 지원을 바탕으로 한 잔혹성 테스트의 추진은 동물실험법으로부터의 전환을 가속화하고 있습니다. 또한 연구 자금 증가와 규제 당국 및 민간 단체와의 공동 연구는 혁신적인 솔루션 개발을 촉진하고 있습니다. 끊임없는 기술 발전과 안전에 대한 관심 증가로 인해 시장은 향후 수년간 지속적인 성장을 이룰 준비가 되어 있습니다.
부문
유형(경피독성 시험 서비스, 경피독성 시험 제품), 시험 방법(인비트로 시험 방법, 인비보 시험 방법, 인실리코 모델링 시험 방법), 시험 유형(피부 감작성 시험, 피부 자극성 시험, 피부 부식성 시험, 광독성 시험), 최종사용자(헬스케어 산업 최종사용자, 화장품 및 퍼스널케어 제품 최종사용자, 화학 최종사용자, 기타 최종사용자)
조사 대상 기업의 예
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Catalent, Inc.
Charles River Laboratories International, Inc.
Covance Inc.(now part of Labcorp)
Cyprotex(a subsidiary of Evotec SE)
Eurofins Scientific Inc.
Evotec SE
GE Healthcare
Intertek Group plc
InVivo Biosystems
MatTek Corporation
Merck KGaA
Promega Corporation
Qiagen N.V.
QIMA Ltd.
Quest Diagnostics Incorporated
SGS S.A.
Thermo Fisher Scientific Inc.
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Dermal Toxicity Testing Market to Reach US$4.1 Billion by 2030
The global market for Dermal Toxicity Testing estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.1 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. Dermal Toxicity Testing Services, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.4 Billion by the end of the analysis period. Growth in the Dermal Toxicity Testing Products segment is estimated at 5.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$699.1 Million While China is Forecast to Grow at 7.2% CAGR
The Dermal Toxicity Testing market in the U.S. is estimated at US$699.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.6 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
Why Is The Demand For Dermal Toxicity Testing Increasing Rapidly?
The global dermal toxicity testing market is experiencing rapid growth due to the rising need for safe and effective skincare, pharmaceuticals, and chemical products. As regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Chemicals Agency (ECHA) impose stringent safety standards, companies must ensure that their products do not cause skin irritation, sensitization, or long-term dermal damage. The cosmetics and personal care industry, in particular, has witnessed a surge in demand for cruelty-free and non-animal-tested products, further driving the adoption of alternative dermal toxicity testing methods. Additionally, increasing consumer awareness of the potential adverse effects of synthetic chemicals has encouraged manufacturers to prioritize rigorous safety evaluations. With the expanding landscape of dermatological research and the rise in skin-related disorders, the demand for comprehensive dermal toxicity testing continues to grow.
How Are Technological Innovations Transforming The Dermal Toxicity Testing Market?
Technological advancements have significantly revolutionized the dermal toxicity testing landscape, introducing more reliable, ethical, and cost-effective solutions. The adoption of in vitro testing methods, such as 3D human skin models, has provided a superior alternative to traditional animal testing, offering higher accuracy in predicting human skin reactions. Additionally, high-throughput screening (HTS) techniques and advanced bioinformatics tools have accelerated toxicity analysis, allowing researchers to assess multiple compounds simultaneously. The integration of artificial intelligence (AI) and machine learning in toxicity prediction has further enhanced data analysis, improving efficiency and precision in toxicity assessment. Furthermore, regulatory bodies are increasingly advocating for in silico (computer-based) modeling techniques, which enable virtual simulations of skin interactions with chemicals. These technological breakthroughs are shaping the future of dermal toxicity testing, ensuring safer and more ethical product development.
What Are The Major Challenges Affecting The Dermal Toxicity Testing Market?
Despite the progress in the field, several challenges continue to affect the growth and standardization of dermal toxicity testing. One of the primary obstacles is the complexity of human skin biology, making it difficult to create universally applicable in vitro models. While alternative methods have made strides in replacing animal testing, regulatory validation and global acceptance of these models remain slow, delaying widespread adoption. Additionally, the high costs associated with advanced testing techniques and the need for skilled professionals pose financial and operational barriers for smaller companies. Moreover, discrepancies in safety regulations across different countries create compliance challenges for multinational businesses, necessitating continuous adaptation to region-specific testing requirements. Addressing these issues through increased regulatory harmonization, investment in research, and cost-effective innovations will be essential for the sustained expansion of the dermal toxicity testing market.
What Factors Are Driving The Growth Of The Dermal Toxicity Testing Market?
The growth in the dermal toxicity testing market is driven by several factors, including rising regulatory scrutiny, increasing consumer demand for safe and ethical products, and advancements in alternative testing methodologies. The growing adoption of in vitro and in silico testing approaches, along with AI-driven predictive modeling, has enhanced the reliability and efficiency of toxicity assessments. Additionally, the expansion of the pharmaceutical, cosmetic, and chemical industries has intensified the need for stringent safety evaluations, propelling market growth. The push for cruelty-free testing, backed by government regulations and advocacy groups, has accelerated the transition away from animal testing methods. Furthermore, increased research funding and collaborations between regulatory agencies and private organizations are fostering the development of innovative dermal toxicity testing solutions. With continuous technological progress and a rising focus on safety, the market is poised for sustained growth in the coming years.
SCOPE OF STUDY:
The report analyzes the Dermal Toxicity Testing market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Type (Dermal Toxicity Testing Services, Dermal Toxicity Testing Products); Testing Method (In-Vitro Testing Method, In-Vivo Testing Method, In-Silico Modeling Testing Method); Test Type (Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests, Phototoxicity Tests); End-Use (Healthcare industry End-Use, Cosmetics and Personal Care Products End-Use, Chemical End-Use, Other End-Uses)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 32 Featured) -
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Catalent, Inc.
Charles River Laboratories International, Inc.
Covance Inc. (now part of Labcorp)
Cyprotex (a subsidiary of Evotec SE)
Eurofins Scientific Inc.
Evotec SE
GE Healthcare
Intertek Group plc
InVivo Biosystems
MatTek Corporation
Merck KGaA
Promega Corporation
Qiagen N.V.
QIMA Ltd.
Quest Diagnostics Incorporated
SGS S.A.
Thermo Fisher Scientific Inc.
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Dermal Toxicity Testing - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for Cosmetic and Pharmaceutical Product Safety Throws the Spotlight on Dermal Toxicity Testing
Global Regulatory Compliance Requirements Spur Adoption of In Vitro and Alternative Testing Models
Shift Away from Animal Testing Strengthens the Business Case for Reconstructed Human Epidermis Models
Growth of Personal Care, Chemical, and Agrochemical Sectors Drives Expanded Testing Pipelines
Technological Innovation in Skin-on-a-Chip and Microfluidic Models Enhances Accuracy and Scalability
Increased Use of Predictive Toxicology and AI-Driven Screening Supports Non-Animal Safety Assessment
OECD and REACH Guidelines Shape Standardized Testing Protocols for Global Market Access
Emerging Demand for Rapid Toxicity Screening Tools Fuels Investment in High-Throughput Platforms
Expansion of Toxicity Testing in Nanomaterials and Biologics Creates Demand for Specialized Protocols
Growing Pharmaceutical Outsourcing Trends Drive Use of CROs and Contract Testing Laboratories
Consumer Advocacy and Ethical Branding Pressures Encourage Adoption of Cruelty-Free Testing Methods
Toxicology Data Integration with Risk Assessment Platforms Enhances Product Development Speed
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Dermal Toxicity Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Dermal Toxicity Testing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Dermal Toxicity Testing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Dermal Toxicity Testing Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Healthcare industry End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Healthcare industry End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Cosmetics & Personal Care Products End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Cosmetics & Personal Care Products End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Chemical End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Chemical End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for In-Vitro Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for In-Vitro Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for In-Vivo Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for In-Vivo Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for In-Silico Modeling Testing Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for In-Silico Modeling Testing Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Skin Sensitization Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Skin Sensitization Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Skin Irritation Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Skin Irritation Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Skin Corrosion Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Skin Corrosion Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Phototoxicity Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Phototoxicity Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 30: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 31: USA 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 33: USA 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 35: USA 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 36: USA Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 37: USA 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 40: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 41: Canada 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 42: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 43: Canada 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
JAPAN
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 46: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 47: Japan 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 48: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 49: Japan 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: Japan 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 52: Japan Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 53: Japan 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
CHINA
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 54: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 55: China 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: China 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 58: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 59: China 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 60: China Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 61: China 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
EUROPE
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 62: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 63: Europe 6-Year Perspective for Dermal Toxicity Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 64: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 65: Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 66: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 67: Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 70: Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 71: Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
FRANCE
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 72: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 73: France 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: France 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 76: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 77: France 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 78: France Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 79: France 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
GERMANY
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: Germany 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 82: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 83: Germany 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 84: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 85: Germany 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Germany 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
ITALY
TABLE 88: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 89: Italy 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 90: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 91: Italy 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Italy 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 94: Italy Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 95: Italy 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
UNITED KINGDOM
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 96: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 97: UK 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 98: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: UK 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 100: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 101: UK 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 102: UK Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 103: UK 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
REST OF EUROPE
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 107: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 109: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Rest of Europe 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
ASIA-PACIFIC
Dermal Toxicity Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 113: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 115: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 119: Asia-Pacific 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
REST OF WORLD
TABLE 120: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Type - Dermal Toxicity Testing Services and Dermal Toxicity Testing Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 121: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Type - Percentage Breakdown of Value Sales for Dermal Toxicity Testing Services and Dermal Toxicity Testing Products for the Years 2025 & 2030
TABLE 122: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by End-Use - Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of World 6-Year Perspective for Dermal Toxicity Testing by End-Use - Percentage Breakdown of Value Sales for Healthcare industry End-Use, Cosmetics & Personal Care Products End-Use, Chemical End-Use and Other End-Uses for the Years 2025 & 2030
TABLE 124: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Testing Method - In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 125: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Testing Method - Percentage Breakdown of Value Sales for In-Vitro Testing Method, In-Vivo Testing Method and In-Silico Modeling Testing Method for the Years 2025 & 2030
TABLE 126: Rest of World Recent Past, Current & Future Analysis for Dermal Toxicity Testing by Test Type - Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 127: Rest of World 6-Year Perspective for Dermal Toxicity Testing by Test Type - Percentage Breakdown of Value Sales for Skin Sensitization Tests, Skin Irritation Tests, Skin Corrosion Tests and Phototoxicity Tests for the Years 2025 & 2030
